substance p has been researched along with Nervous System Disorders in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eapen, PM; Nampoothiri, M; Rao, CM | 1 |
| Grippo, AJ; Scotti, MA | 1 |
| Bodfish, JW; Dahl, N; Hardrict, R; Kennedy, W; Symons, FJ; Wendelschafer-Crabb, G | 1 |
| Albuquerque, RH; Bannister, R; Barnes, AJ; Bishop, AE; Bloom, SR; Long, RG; McGregor, GP; O'Shaughnessy, DJ; Polak, JM | 1 |
| Krieger, DT; Martin, JB | 1 |
| Neumayr, A | 1 |
| Ballenger, JC; Bunney, WE; Gold, P; Goodwin, FK; Post, RM; Rubinow, DR | 1 |
| Blyth, WA; Easty, DL; Hill, TJ; Keen, P; Tullo, AB | 1 |
| Brown, MR; Buck, SH; Burks, TF; Davis, TP; Walsh, JH; Yamamura, HI | 1 |
| Beal, MF; Landis, DM; Marshall, PE; Martin, JB; Sagar, SM | 1 |
| Itoga, E; Kamiya, K; Kishida, K; Kito, S; Yanaihara, N | 1 |
| Gebhart, GF; Maves, TJ; Meller, ST | 1 |
| Malek-Ahmadi, P | 1 |
| Chae, HY; Parvin, CA; Roth, KA; Schmidt, RE | 1 |
| Apfel, SC; Arezzo, JC; Kessler, JA; Lipton, RB | 1 |
| Cramer, H; Geiger, J; Jost, S; Milios, E; Mundinger, F; Reuner, C | 1 |
| Almay, BGL; Johansson, F; Le Grevés, P; Terenius, L; Von Knorring, L | 1 |
5 review(s) available for substance p and Nervous System Disorders
| Article | Year |
|---|---|
Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders.
Topics: Animals; Brain; Humans; Nervous System Diseases; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Signal Transduction; Substance P | 2019 |
Stress and neuroinflammation.
Topics: Animals; Catecholamines; Cyclooxygenase 2; Cytokines; Glucocorticoids; Humans; Inflammation; Nervous System Diseases; Neuropeptide Y; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Stress, Psychological; Substance P | 2013 |
Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function.
Topics: Adrenocorticotropic Hormone; Angiotensins; beta-Endorphin; Calcitonin; Endorphins; Humans; Mental Disorders; Nervous System Diseases; Oxytocin; Peptides; Somatostatin; Substance P; Vasoactive Intestinal Peptide; Vasopressins; Vasotocin | 1982 |
Implications of neuropeptides in neurological diseases.
Topics: Alzheimer Disease; Animals; Brain; Cholecystokinin; Choline O-Acetyltransferase; Endorphins; Epilepsy; Forecasting; Histocytochemistry; Humans; Huntington Disease; Migraine Disorders; Nerve Tissue Proteins; Nervous System Diseases; Pain; Parkinson Disease; Radioimmunoassay; Somatostatin; Substance P; Thyrotropin-Releasing Hormone; Tissue Distribution; Vasopressins | 1984 |
Substance P and neuropsychiatric disorders: an overview.
Topics: Humans; Mental Disorders; Nervous System Diseases; Substance P | 1992 |
12 other study(ies) available for substance p and Nervous System Disorders
| Article | Year |
|---|---|
Evidence of altered epidermal nerve fiber morphology in adults with self-injurious behavior and neurodevelopmental disorders.
Topics: Adult; Cross-Sectional Studies; Epidermis; Female; Humans; Intellectual Disability; Male; Nerve Fibers; Nervous System Diseases; Self-Injurious Behavior; Substance P | 2008 |
Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas' disease and chronic autonomic failure.
Topics: Autonomic Nervous System; Biopsy; Chagas Disease; Chronic Disease; Gastrointestinal Hormones; Humans; Intestinal Diseases, Parasitic; Nervous System Diseases; Rectum; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1980 |
Brain peptides (second of two parts).
Topics: Acupuncture Therapy; Animals; Body Temperature Regulation; Brain; Brain Diseases; Cerebrospinal Fluid; Cholecystokinin; Endorphins; Enkephalins; Epilepsy; Feeding Behavior; Humans; Learning; Memory; Nervous System Diseases; Neurotransmitter Agents; Pain; Peptides; Pituitary Hormones; Substance P; Synaptic Transmission | 1981 |
[The APUD concept and its clinical significance. 2. Effect of gastrointestinal hormones, polypeptides and neurotransmitters on the physiological course and disease processes of the intestinal tract and the nervous system].
Topics: APUD Cells; Cholecystokinin; Hormones; Humans; Intestinal Diseases; Neoplasms; Nervous System Diseases; Neurotensin; Neurotransmitter Agents; Peptides; Substance P | 1982 |
Corneal sensitivity and substance P in experimental herpes simplex keratitis in mice.
Topics: Animals; Blinking; Keratitis, Dendritic; Male; Muridae; Nervous System Diseases; Sensation; Substance P | 1983 |
Characterization of the peptide and sensory neurotoxic effects of capsaicin in the guinea pig.
Topics: Animals; Capsaicin; Cholecystokinin; Dose-Response Relationship, Drug; Ganglia, Spinal; Guinea Pigs; Morphine; Nerve Tissue Proteins; Nervous System Diseases; Neurons, Afferent; Nociceptors; Peripheral Nerves; Somatostatin; Spinal Cord; Substance P; Vasoactive Intestinal Peptide | 1983 |
[Substance P and the nervous system--with special reference to its clinical significance].
Topics: Adult; Animals; Central Nervous System; Female; Humans; Male; Middle Aged; Nervous System Diseases; Rats; Substance P | 1979 |
Neonatal capsaicin treatment prevents the development of the thermal hyperalgesia produced in a model of neuropathic pain in the rat.
Topics: Animals; Animals, Newborn; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Hot Temperature; Male; Nervous System Diseases; Pain; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 1992 |
Neuroaxonal dystrophy in aging human sympathetic ganglia.
Topics: Adult; Aged; Aging; Autopsy; Axons; Enkephalin, Methionine; Ganglia, Sympathetic; Gastrin-Releasing Peptide; Humans; Immunohistochemistry; Microscopy, Electron; Middle Aged; Nervous System Diseases; Neurons; Neuropeptide Y; Peptides; Substance P; Synapses; Time Factors; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide | 1990 |
Nerve growth factor prevents toxic neuropathy in mice.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Behavior, Animal; Electrophysiology; Ganglia, Spinal; Injections, Intraperitoneal; Male; Mice; Nerve Growth Factors; Nervous System Diseases; Neural Conduction; Neurons, Afferent; Paclitaxel; Reaction Time; Substance P | 1991 |
Ventricular fluid neuropeptides in Parkinson's disease. II. Levels of substance P-like immunoreactivity.
Topics: Adult; Analysis of Variance; Cerebrospinal Fluid Proteins; Chromatography, High Pressure Liquid; Female; Humans; Immunoassay; Male; Middle Aged; Nervous System Diseases; Parkinson Disease; Reference Values; Substance P | 1991 |
Substance P in CSF of patients with chronic pain syndromes.
Topics: Adult; Aged; Chronic Disease; Depression; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pain; Pain, Intractable; Personality Inventory; Substance P; Syndrome | 1988 |